1. Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy. Issue 3 (9th March 2021) Authors: Olivo Pimentel, Veronica; Marcus, Damiënne; van der Wiel, Alexander MA; Lieuwes, Natasja G; Biemans, Rianne; Lieverse, Relinde IY; Neri, Dario; Theys, Jan; Yaromina, Ala; Dubois, Ludwig J; Lambin, Philippe Journal: Journal for immunotherapy of cancer Issue: Volume 9:Issue 3(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗